[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340766-105":59,"doc-detail-340766-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cuproptosis-related-gene-fdx1-suppresses-the-growth-and-progression-of-colorectal-cancer-by-retarding-emt-progress","Cuproptosis-Related Gene FDX1 Suppresses the Growth and Progression of Colorectal Cancer by Retarding EMT Progress","","Colorectal cancer (CRC) remains a lethal malignancy, and the cuproptosis-related gene ferredoxin 1 (FDX1) has been reported as a suppressor in multiple cancers. TCGA analysis shows reduced FDX1 expression in COAD/CRC tissues and worse patient prognosis with lower FDX1. Experimental validation confirms FDX1 downregulation in CRC tissues and cells, linking FDX1 with EMT markers and inhibiting CRC viability, invasion, and migration. EMT inhibition by FDX1 overexpression is reversed by EGF treatment, indicating that FDX1 suppresses CRC growth and progression via EMT restraint.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cuproptosis-related-gene-fdx1-suppresses-the-growth-and-progression-of-colorectal-cancer-by-retarding-emt-progress/340766/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cuproptosis-related-gene-fdx1-suppresses-the-growth-and-progression-of-colorectal-cancer-by-retarding-emt-progress/340766.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does FDX1 play in colorectal cancer progression?","Question",{"text":112,"@type":113},"FDX1 suppresses CRC growth and progression by retarding epithelial–mesenchymal transition (EMT). Overexpression of FDX1 inhibits CRC cell viability, invasion, and migration, and also reduces tumor growth and metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was FDX1 expression analyzed in the study?",{"text":117,"@type":113},"Focusing on COAD/CRC, the study first used the TCGA database to show lower FDX1 expression associated with worse prognosis. It then verified downregulation of FDX1 in CRC tissues and cells using experimental measurements.",{"name":119,"@type":110,"acceptedAnswer":120},"How does EGF affect the effects of FDX1 on EMT and CRC progression?",{"text":121,"@type":113},"EGF is used as an EMT inducer in rescue assays. The study reports that EGF treatment rescues the inhibited CRC progression and reverses EMT retardation caused by FDX1 overexpression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340766,1790268568,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Biochemical Genetics (2025) 63:775–788  \n[https://doi.org/10.1007/s10528-024-10784-8](https://doi.org/10.1007/s10528-024-10784-8)  \nORIGINAL ARTICLE  \nCuproptosis‑Related Gene FDX1 Suppresses the Growth and Progression of Colorectal Cancer by Retarding EMT Progress  \nChao Wang1 · Jingjing Guo1 · Yun Zhang1 · Shusheng Zhou1 · Bing Jiang2  \nReceived: 15 September 2023 / Accepted: 28 January 2024 / Published online: 23 March 2024 © The Author(s) 2024  \nAbstract  \nColorectal cancer (CRC) is a usual cancer and a kind of lethiferous cancer. Cuproptosis-related gene ferredoxin 1 (FDX1) has been discovered to act as a suppressor, thereby suppressing some cancers’ progression. But, the regulatory functions of FDX1 in CRC progression keep vague. In this work, at first, through TCGA database, it was revealed that FDX1 exhibited lower expression in COAD (colon adenocarcinoma) tissues, and CRC patients with lower FDX1 expression had worse prognosis. Furthermore, FDX1 expression was verified to be down-regulated in CRC tissues (n = 30) and cells. It was further uncovered that FDX1 expression was positively correlated with CDH1 and TJP1 (epithelial marker), and negatively correlated with CDH2, TWIST1, and FN1 (stromal marker), suggesting that FDX1 was closely associated with the epithelial–mesenchymal transition (EMT) progress. Next, it was demonstrated that overexpression of FDX1 suppressed cell viability, invasion, and migration in CRC. Furthermore, it was verified that FDX1 retarded the EMT progress in CRC. Lastly, through rescue assays, the inhibited CRC progression mediated by FDX1 overexpression was rescued by EGF (EMT inducer) treatment. At last, it was uncovered that the tumor growth and metastasis were relieved after FDX1 overexpression, but these changes were reversed after EGF treatment. In conclusion, FDX1 inhibited the growth and progression of CRC by inhibiting EMT progress. This discovery hinted that FDX1 may act as an effective candidate for CRC treatment.  \nKeywords FDX1 · Colorectal cancer · EMT progress · EGF  \n* Chao Wang [wangchao@ahmu.edu.cn](wangchao@ahmu.edu.cn)  \n1 Department of Internal Medicine Oncology, Chaohu Hospital of Anhui Medical University, No.  \n64, Chaohu North Road, Juchao District, Chaohu 238000, Anhui, China  \n2 Department of Gastrointestinal Surgery, Chaohu Hospital of Anhui Medical University, Chaohu 238000, Anhui, China  \nIntroduction  \nCurrently, colorectal cancer (CRC) is the top three tumors for incidence and the second highest for mortality (Baidoun et al. 2021 ; Dekker et al. 2019) . There isabout 1.9 million new cancer cases and 0.9 million cancer deaths in 2020 (Sunget al. 2021) . Additionally, the incidence of CRC in 2020 still accounts for 10% of the total cancer cases, and 3.2 million new cases have been expected by 2040 (Morgan et al. 2023 ; Sung et al. 2021) . The prognosis of CRC is largely affected by clinicopathological features and tumor stage (Dienstmann et al. 2019) . The effective early screening has relieved the incidence of severe CRC patients, and some treatment (such as targeted therapy, immunotherapy, chemotherapy) have contributed to the decline in morbidity and mortality of CRC (Biller and Schrag 2021) . However, more than 50% of CRC patients are still diagnosed with advanced stages, seriously threatening their lives (Benson 2007) . Now, the mean age of onset is lower, and the 5-year survival rate for CRC patients with distant metastasis is under 10%(Erickson 2018) . For obtaining effective treatment strategies, it is needful to conduct investigations into the carcinogenicity of CRC to seek new and promising biomarkers.  \nCopper death is a novel discovered mechanism of cell death (Jiang et al. 2022) . The main mechanism of copper death is that the direct targeting of copper to the fatty acylation component of the tricarboxylic (TCA) cycle, followed by the loss of iron-sulfur cluster protein, which brings about protein toxic stress and ultimately cell death (Tsvetkov et al. ","cbCaidZPh2sZ231Q","https://ap.wps.com/l/cbCaidZPh2sZ231Q","pdf",2406977,14,"English","# Abstract\n# Introduction\n# Materials and Methods\n## Tissue Samples","[{\"question\":\"What role does FDX1 play in colorectal cancer progression?\",\"answer\":\"FDX1 suppresses CRC growth and progression by retarding epithelial–mesenchymal transition (EMT). Overexpression of FDX1 inhibits CRC cell viability, invasion, and migration, and also reduces tumor growth and metastasis.\"},{\"question\":\"How was FDX1 expression analyzed in the study?\",\"answer\":\"Focusing on COAD/CRC, the study first used the TCGA database to show lower FDX1 expression associated with worse prognosis. It then verified downregulation of FDX1 in CRC tissues and cells using experimental measurements.\"},{\"question\":\"How does EGF affect the effects of FDX1 on EMT and CRC progression?\",\"answer\":\"EGF is used as an EMT inducer in rescue assays. The study reports that EGF treatment rescues the inhibited CRC progression and reverses EMT retardation caused by FDX1 overexpression.\"}]","Cuproptosis-Related Gene FDX1 Suppresses the Growth and Progression of Colorectal Cancer by Retarding EMT Progress | PDF",1790038818,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b14be3ecfba59cd9ed88139bd60c4d5.webp",983,1415,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51d5a39ba6ee4b35f2e313562b849677.webp",982,1414,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/339c2f4d9ea158d28f5a48244b770405.webp",981,1412,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5157e46cf6342e74a597bb11e113e04c.webp",980,1411]